The Community Guide

- gsearch

Search Results

Narrow Results:

2019 1
2018 1

Kenya 1
Thailand 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial

CITE Title : Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial Personal Author(s) : Meya, David B.;Kiragga, Agnes N.;Nalintya, Elizabeth;Morawski, Bozena M.;Rajasingham, Radha;Park, Benjamin J.;Mubiru, Anthony;Kaplan, Jonathan E.;Manabe, Yukari C.;Boulware, David R.; Published Date : Feb 01 2019;2-1-; Source : J Acquir Immune Defic Syndr. 2018; 80(2):182-189 URL : https://stacks.cdc.gov/view/cdc/77380 Meya, David B. et al. (2019). Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial. 80(2). Meya, David B. et al. "Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial" 80, no. 2 (2019) Meya, David B. et al. "Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial" vol. 80, no. 2, 2019 Export RIS Citation Information.

:

Meya, David B. ;

Kiragga, Agnes N.

Feb 01 2019 | J Acquir Immune Defic Syndr. 2018; 80(2):182-189

:

Background:HIV-infected persons with cryptococcal antigenemia (CrAg) are at high risk for meningitis or death. We evaluated the effect of CrAg screeni...
Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya

CITE Title : Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya Personal Author(s) : Bahr, Nathan C.;Lee, Deborah;Stauffer, William M.;Durkin, Michelle;Cetron, Martin S.;Wheat, L. Joseph;Boulware, David R.; Published Date : Apr 2018 Source : J Immigr Minor Health. 20(2):334-338 URL : https://stacks.cdc.gov/view/cdc/56983 Bahr, Nathan C. et al. (2018). Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya. 20(2). Bahr, Nathan C. et al. "Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya" 20, no. 2 (2018) Bahr, Nathan C. et al. "Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya" vol. 20, no. 2, 2018 Export RIS Citation Information.

:

Bahr, Nathan C. ;

Lee, Deborah

Apr 2018 | J Immigr Minor Health. 20(2):334-338

:

Histoplasmosis is known to be endemic to the Midwestern United States, but cases have been reported throughout much of the world. Somali, Hmong, and B...